Kikawa Y, Inuzuka M, Jin B Y, Kaji S, Koga J, Yamamoto Y, Fujisawa K, Hata I, Nakai A, Shigematsu Y, Mizunuma H, Taketo A, Mayumi M, Sudo M
Department of Pediatrics, Fukui Medical School, Matsuoka, Japan.
Am J Hum Genet. 1997 Oct;61(4):852-61. doi: 10.1086/514875.
Fructose-1,6-bisphosphatase (FBPase) deficiency is an autosomal recessive inherited disorder and may cause sudden unexpected infant death. We reported the first case of molecular diagnosis of FBPase deficiency, using cultured monocytes as a source for FBPase mRNA. In the present study, we confirmed the presence of the same genetic mutation in this patient by amplifying genomic DNA. Molecular analysis was also performed to diagnose another 12 Japanese patients with FBPase deficiency. Four mutations responsible for FBPase deficiency were identified in 10 patients from 8 unrelated families among a total of 13 patients from 11 unrelated families; no mutation was found in the remaining 3 patients from 3 unrelated families. The identified mutations included the mutation reported earlier, with an insertion of one G residue at base 961 in exon 7 (960/961insG) (10 alleles, including 2 alleles in the Japanese family from our previous report [46% of the 22 mutant alleles]), and three novel mutations--a G-->A transition at base 490 in exon 4 (G164S) (3 alleles [14%]), a C-->A transversion at base 530 in exon 4 (A177D) (1 allele [4%]), and a G-->T transversion at base 88 in exon 1 (E30X) (2 alleles [9%]). FBPase proteins with G164S or A177D mutations were enzymatically inactive when purified from E. coli. Another new mutation, a T-->C transition at base 974 in exon 7 (V325A), was found in the same allele with the G164S mutation in one family (one allele) but was not responsible for FBPase deficiency. Our results indicate that the insertion of one G residue at base 961 was associated with a preferential disease-causing alternation in 13 Japanese patients. Our results also indicate accurate carrier detection in eight families (73%) of 11 Japanese patients with FBPase deficiency, in whom mutations in both alleles were identified.
果糖-1,6-二磷酸酶(FBPase)缺乏症是一种常染色体隐性遗传疾病,可能导致婴儿意外猝死。我们报道了首例利用培养的单核细胞作为FBPase mRNA来源进行FBPase缺乏症分子诊断的病例。在本研究中,我们通过扩增基因组DNA证实了该患者存在相同的基因突变。我们还对另外12例日本FBPase缺乏症患者进行了分子分析。在来自11个无关家庭的13例患者中,8个无关家庭的10例患者鉴定出了导致FBPase缺乏症的4种突变;来自3个无关家庭的其余3例患者未发现突变。鉴定出的突变包括先前报道的突变,即外显子7中第961位碱基插入一个G残基(960/961insG)(10个等位基因,包括我们先前报道的日本家庭中的2个等位基因[占22个突变等位基因的46%]),以及3种新突变——外显子4中第490位碱基由G→A转换(G164S)(3个等位基因[14%])、外显子4中第530位碱基由C→A颠换(A177D)(1个等位基因[4%])、外显子1中第88位碱基由G→T颠换(E30X)(2个等位基因[9%])。从大肠杆菌中纯化的具有G164S或A177D突变的FBPase蛋白无酶活性。在一个家庭的一个等位基因中发现了另一种新突变,即外显子7中第974位碱基由T→C转换(V325A),但该突变与FBPase缺乏症无关,它与G164S突变位于同一个等位基因上。我们的结果表明,在13例日本患者中,第961位碱基插入一个G残基与优先导致疾病的改变相关。我们的结果还表明,在11例日本FBPase缺乏症患者的8个家庭(73%)中能够准确检测出携带者,这些家庭中两个等位基因的突变均已鉴定出来。